Physician profile
Jagdeep Singh
NPI 1548482458
$3,341.92
in general payments reported to CMS, 2019-2025
40 companies · $570 in 2025
The $570 reported for 2025 was more than what 76% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $497 · 2020: $387 · 2021: $475 · 2022: $483 · 2023: $380 · 2024: $550 · 2025: $570.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,501.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,500.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $381.12 | 2020-2024 | Vraylar, Dalvance |
| Lilly USA, LLC | $373.53 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $331.56 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Novo Nordisk INC | $307.12 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Takeda Pharmaceuticals U.S.A., INC. | $173.56 | 2020-2023 | Trintellix |
| Amgen INC. | $167.14 | 2019-2024 | Repatha |
| Exact Sciences Corporation | $155.50 | 2023-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $153.16 | 2019-2025 | Veozah |
| Astrazeneca Pharmaceuticals LP | $134.31 | 2019-2025 | Breztri, Airsupra |
| Dexcom, INC. | $127.59 | 2022-2025 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.79 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $93.43 | 2021-2022 | |
| Phathom Pharmaceuticals, INC. | $87.06 | 2024-2025 | Voquezna |
| Esperion Therapeutics, INC. | $69.98 | 2020-2024 | Nexletol |
| Merck Sharp & Dohme LLC | $68.34 | 2020-2021 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jagdeep Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.